Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01415583).
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: Complete Statistical AnalysisIndependent statistical analysis of Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA: primary endpoint results, effect estimate with confidence interval, sample-size…
- Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313923).
- Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating Strategies to Present Colon Cancer Screening Information: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Strategies to Present Colon Cancer Screening Information: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02485561).
- Evaluating Telementoring for CHW-centered Diabetes Initiatives: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Telementoring for CHW-centered Diabetes Initiatives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04835493).
- Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy: primary endpoint results, effect estimate with confidence…
- Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection: primary endpoint results, effect…
- Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome: primary endpoint results, effect estimate with confidence interval,…
- Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.: primary endpoint results, effect estimate with…
- Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Feasibility of VR for Pediatric Renal Biopsies: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Feasibility of VR for Pediatric Renal Biopsies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05267704).
- Evaluating the Impact of JJVC Senofilcon A – Based Contact Lens With New UV-blocker on Day and Night Driving Performance: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance: primary endpoint results, effect estimate with confidence interval,…
- Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03626766).
- Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age: primary endpoint results, effect estimate…
- Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children: primary endpoint results, effect…
- Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children: primary endpoint results, effect estimate with…
- Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Need for Pneumatic Compression Devices: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Need for Pneumatic Compression Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02641080).
- Evaluating the Non-Inferiority of Airmod to Capnostream™35: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Non-Inferiority of Airmod to Capnostream™35: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05263791).
- Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women: primary endpoint results, effect estimate with confidence interval,…
- Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults: primary endpoint results, effect estimate…
- Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size…
- Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults: primary endpoint results, effect estimate with confidence interval,…
- Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants: primary…
- Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…